153 related articles for article (PubMed ID: 38605935)
1. A qualitative study evaluating COVID-19 vaccine hesitancy among individuals living in Mississippi.
Leigland A; Arnold T; Giorlando KK; Barnett AP; Sims-Gomillia CE; Bertone Z; Edet PP; Whiteley L; Brown LK
SSM Qual Res Health; 2024 Jun; 5():. PubMed ID: 38605935
[TBL] [Abstract][Full Text] [Related]
2. Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study.
Ali F; Kaura A; Russell C; Bonn M; Bruneau J; Dasgupta N; Imtiaz S; Martel-Laferrière V; Rehm J; Shahin R; Elton-Marshall T
Harm Reduct J; 2023 Jul; 20(1):99. PubMed ID: 37516836
[TBL] [Abstract][Full Text] [Related]
3. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.
Godbole S; Diwan V; Das S; Reddy MM; Kalyanasundaram M; Rajendran D; Biswas D; Mamulwar M; Tiwari RR; Majumder J; Mishra A; Muthusamy SK; Memeenao M; Gupta N; Gupta S; George LS; Kadale P; Trushna T; Saha I; Alam U; Kathiresan J; Phukan SK; Sane S; Bhowmik K; Yadav GK; Krishnamurthy V; Gogoi P; Padhye K; Kant R; Ghosh P; Kharat M; Kulkarni A
Front Public Health; 2023; 11():1293600. PubMed ID: 38328539
[TBL] [Abstract][Full Text] [Related]
4. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of COVID-19 Vaccine and PrEP Hesitancy Among Individuals Living in Mississippi: A Qualitative Study.
Arnold T; Barnett AP; Giorlando KK; Leigland A; Sims-Gomillia C; Whiteley L; Brown LK
AIDS Behav; 2023 Oct; 27(10):3515-3520. PubMed ID: 37071335
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
7. Facilitators of and barriers to COVID-19 vaccination in Grenada: a qualitative study.
Herry AM; Greaves D; Smith P; Toledo NA; Wildman A; Wildman T; Browne R; Chen M; Jones M; Aymat S
Rev Panam Salud Publica; 2023; 47():e44. PubMed ID: 36945250
[TBL] [Abstract][Full Text] [Related]
8. Informing efforts beyond tailored promotional campaigns by understanding contextual factors shaping vaccine hesitancy among equity-deserving populations in Canada: an exploratory qualitative study.
Nascimento LG; Dubé È; Burns KE; Brown P; Calnan M; Ward PR; Filice E; Herati H; Ike NAU; Rotolo B; Meyer SB
Int J Equity Health; 2023 Oct; 22(1):209. PubMed ID: 37805472
[TBL] [Abstract][Full Text] [Related]
9. Understanding facilitators and barriers to COVID-19 vaccination in the Zimbabwean population: a qualitative analysis.
Midzi N; Mutsaka-Makuvaza MJ; Charimari LS; Mangwiro P; Manengureni T; Mugadza G
BMC Public Health; 2024 Apr; 24(1):1174. PubMed ID: 38679733
[TBL] [Abstract][Full Text] [Related]
10. Ethnic/racial minorities' and migrants' access to COVID-19 vaccines: A systematic review of barriers and facilitators.
Abba-Aji M; Stuckler D; Galea S; McKee M
J Migr Health; 2022; 5():100086. PubMed ID: 35194589
[TBL] [Abstract][Full Text] [Related]
11. Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis.
Panisset MG; Kilpatrick T; Cofré Lizama LE; Galea MP
Mult Scler Relat Disord; 2022 Jul; 63():103933. PubMed ID: 35671672
[TBL] [Abstract][Full Text] [Related]
12. Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders' Perspectives.
Russ S; Bennett N; van Wijngaarden E; Hill E; Liu Y
Vaccine; 2024 Feb; 42(5):1160-1167. PubMed ID: 38272763
[TBL] [Abstract][Full Text] [Related]
13. A qualitative inquiry on drivers of COVID-19 vaccine hesitancy among adults in Kenya.
Orangi S; Mbuthia D; Chondo E; Ngunu C; Kabia E; Ojal J; Barasa E
PLOS Glob Public Health; 2024; 4(3):e0002986. PubMed ID: 38547132
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Scope and Dimensions of Vaccine Hesitancy and Resistance to Enhance COVID-19 Vaccination in Black Communities.
Okoro O; Kennedy J; Simmons G; Vosen EC; Allen K; Singer D; Scott D; Roberts R
J Racial Ethn Health Disparities; 2022 Dec; 9(6):2117-2130. PubMed ID: 34553340
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.
Huang W; Dove-Medows E; Shealey J; Sanchez K; Benson L; Seymore DD; Sullivan PS; Bradley HM; Siegler AJ
BMC Public Health; 2023 Jan; 23(1):88. PubMed ID: 36631819
[TBL] [Abstract][Full Text] [Related]
16. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community.
Govere-Hwenje S; Jarolimova J; Yan J; Khumalo A; Zondi G; Ngcobo M; Wara NJ; Zionts D; Bogart LM; Parker RA; Bassett IV
BMC Public Health; 2022 Jun; 22(1):1239. PubMed ID: 35733209
[TBL] [Abstract][Full Text] [Related]
17. Barriers to the success of COVID-19 immunisation programs in New Ireland Province, Papua New Guinea.
Flanagan B; Nevill K; Sabok C; Zilliacus M; Sward J
Rural Remote Health; 2023 Sep; 23(3):7883. PubMed ID: 37730242
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators.
Maisa A; Milligan S; Quinn A; Boulter D; Johnston J; Treanor C; Bradley DT
Public Health; 2018 Sep; 162():111-117. PubMed ID: 30007172
[TBL] [Abstract][Full Text] [Related]
19. "They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
Capurro G; Maier R; Tustin J; Jardine CG; Michelle Driedger S
Vaccine; 2022 Nov; 40(50):7280-7287. PubMed ID: 36334965
[TBL] [Abstract][Full Text] [Related]
20.
Newman PA; Dinh DA; Massaquoi N; Williams CC; Lacombe-Duncan A; Tepjan S; Nyoni T
Hum Vaccin Immunother; 2024 Dec; 20(1):2301189. PubMed ID: 38346919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
